Figure 1From: Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implicationsPathophysiology of the metabolic syndrome: both insulin resistance and lipid overflow contribute to MetS evolution. IL-6, interleukin-6; MAP, mitogen-activated protein; TNF-α, tumor necrosis factor-alpha.Back to article page